“…A previous study has shown that CK7 labels 2 of 3 cases (67%) of porocarcinoma [14]. However, its expression can be seen in 13% to 27% of cases of invasive SCC cases (especially the poorly differentiated ones) and in cutaneous squamous cell carcinoma in-situ [15,16,36]. Similar to these findings, we found the expression of CK7 in 64% and 26% of our porocarcinoma and SCC cases, respectively [14,15].…”